Refractory Treatment Jobs: 9 Stellenangebote

Neu Job vor 6 Std. bei Jobvector gefunden Catal Ym GmbH

Biologist as Quality Assurance Manager (m/f/d)

• Planegg, 82152 Homeoffice möglich Catal Ym is a biotech company based in Martinsried near Munich, developing innovative immunotherapies to transform cancer patients lives by effectively engaging their own immune[...]

MEHR INFOS ZUM STELLENANGEBOT

[...] lives by effectively engaging their own immune systems to combat this malignant disease. We are now advancing to Phase 2b studies to confirm visugromab, our lead antibody, that has demonstrated durable anti-tumor efficacy with long-lasting objective responses in relapsed and refractory metastatic solid tumor patients in combination with anti-PD-1 treatment. Our mission is to rapidly bring our next-generation immuno-oncology products to patients in need. Are you ready to board the [...]
Alle Quality Assurance Manager Stellenangebote anzeigen

Job vor 11 Tagen bei Jobleads gefunden

Computational Immunologist

• Erlangen, Bayern Computational Immunologist The Grieshaber-Bouyer Lab is seeking a highly motivated scientist with strong expertise in systems immunology, bioinformatics and machine learning interested in continuing their[...]

MEHR INFOS ZUM STELLENANGEBOT

[...] flow cytometry) with clinical data (demographics, medication, laboratory values) and drive forward our development of bioinformatic methods to better integrate different data modalities. The overarching goal of these efforts is to identify new drivers of autoimmune disease heterogeneity, predictors of treatment response, relapse and resistance. Information about the lab: We are a systems immunology group at the Department of Internal Medicine [...] cross species method can be used to improve the translatability of findings between mice and humans. Key References: Hagen Grieshaber-Bouyer. BCMA-Targeted T-Cell Engager Therapy for Autoimmune Disease. N Engl J Med 2024 Bucci Grieshaber-Bouyer. Bispecific T cell engager therapy for refractory rheumatoid arthritis. Nature Medicine 2024 Hackert Grieshaber-Bouyer. Human and murine neutrophils share core transcriptional programs in both homeostatic and inflamed [...]

Job vor 4 Tagen bei NewScientist Jobs gefunden AVEO Oncology

Pharmacovigilance Scientist

• Boston, Massachusetts, United States, Boston Description JOB TITLE: Pharmacovigilance (PV) Scientist DATE PREPARED: February 5, 2025 JOB SUMMARY: The PV Scientist will play a key role in safety surveillance, signal[...]

MEHR INFOS ZUM STELLENANGEBOT

[...] skills, with the ability to work cross-functionally. About AVEO AVEO is a commercial-stage, oncology-focused biopharmaceutical company committed to delivering medicines that provide a better life for patients with cancer. AVEO currently markets FOTIVDA (tivozanib) in the U. S. for the treatment of adult patients with relapsed or refractory renal cell carcinoma (RCC) following two or more prior systemic therapies. AVEO continues to develop FOTIVDA in immuno-oncology combinations in [...]
Alle Pharmacovigilance Scientist Stellenangebote anzeigen

Job vor 4 Tagen bei NewScientist Jobs gefunden Verve Therapeutics, Inc.

Director, Clinical Compliance and Oversight

• Boston, Massachusetts, United States, Boston Führungs-/ Leitungspositionen The Company Verve is a clinical-stage genetic medicines company established with a mission to solve the global health epidemic of cardiovascular disease. Founded by world-leading[...]

MEHR INFOS ZUM STELLENANGEBOT

[...] medicines company established with a mission to solve the global health epidemic of cardiovascular disease. Founded by world-leading experts in cardiovascular medicine, human genetics and gene-editing, Verve is pioneering a new approach to the care of cardiovascular disease, potentially transforming treatment from chronic management to single-course gene editing medicines. The company s initial three programs-VERVE-101, VERVE-102, and VERVE-201-target genes that have [...] atherosclerotic cardiovascular disease (ASCVD) patients not at goal on oral therapy. VERVE-201 is designed to permanently turn off the ANGPTL3 gene in the liver and is initially being developed for homozygous familial hypercholesterolemia (HoFH) and ultimately to treat patients with refractory hypercholesterolemia. In 2024, Verve was named a Top Place to Work by The Boston Globe for the fourth consecutive year. [...]
Alle Oversight Stellenangebote anzeigen

Job vor 9 Tagen bei NewScientist Jobs gefunden Stoke Therapeutics

Director/ Senior Director, Biostatistics

• Cambridge, Massachusetts, United States, Cambridge Führungs-/ Leitungspositionen About Stoke: Stoke Therapeutics (Nasdaq: STOK) , is a biotechnology company dedicated to addressing the underlying cause of severe diseases. The company is pursuing an[...]

MEHR INFOS ZUM STELLENANGEBOT

[...] approach to help people with severe diseases. We recently announced landmark data that support the potential for STK-001 to be the first disease-modifying medicine for Dravet syndrome, a severe and progressive genetic epilepsy that is characterized by frequent, prolonged and refractory seizures, beginning within the first year of life. The disease is classified as a developmental and epileptic encephalopathy due to the developmental delays and cognitive impairment associated with the disease. Stoke is also advancing STK-002, a potential treatment for autosomal dominant optic atrophy (ADOA) , the most common inherited optic nerve disorder. Currently there are no approved treatments [...]
Alle Senior Director Stellenangebote anzeigen

Job vor 9 Tagen bei NewScientist Jobs gefunden Stoke Therapeutics

Clinical Trial Manager, Clinical Operations

• Bedford, Massachusetts, United States, Bedford About Stoke: Stoke Therapeutics (Nasdaq: STOK) , is a biotechnology company dedicated to addressing the underlying cause of severe diseases. The company is pursuing an[...]

MEHR INFOS ZUM STELLENANGEBOT

[...] approach to help people with severe diseases. We recently announced landmark data that support the potential for STK-001 to be the first disease-modifying medicine for Dravet syndrome, a severe and progressive genetic epilepsy that is characterized by frequent, prolonged and refractory seizures, beginning within the first year of life. The disease is classified as a developmental and epileptic encephalopathy due to the developmental delays and cognitive impairment associated with the disease. Stoke is also advancing STK-002, a potential treatment for autosomal dominant optic atrophy (ADOA) , the most common inherited optic nerve disorder. Currently there are no approved treatments [...]
Alle Clinical Trial Manager Stellenangebote anzeigen

Job am 22.03.2025 bei NewScientist Jobs gefunden Northeastern University

Postdoctoral Research Fellow, Arvinas--Global Medical Affairs

• Boston, Massachusetts, United States, Boston About the Opportunity About the Opportunity: Northeastern University Pharmaceutical Industry Fellowships Program is a two-year experiential program designed to advance lifelong learning and the education[...]

MEHR INFOS ZUM STELLENANGEBOT

[...] protein disposal system to selectively and efficiently degrade and remove disease-causing proteins. In addition to its robust preclinical pipeline of PROTAC protein degraders against validated and undruggable targets, the company has three investigational clinical-stage programs currently enrolling: vepdegestrant for the treatment of patients with locally advanced or metastatic ER+/ HER2-breast cancer; ARV-102 for the treatment of patients with neurodegenerative disorders, and ARV-393 for the treatment of patients with relapsed/refractory non-Hodgkin Lymphoma and potentially other lymphomas. In April 2024, Arvinas entered into a transaction with Novartis, including a global license [...]

Job am 22.03.2025 bei NewScientist Jobs gefunden Innoviva Specialty Therapeutics

Director, Clinical Science

• Waltham, Massachusetts, United States, Waltham Führungs-/ Leitungspositionen Company Overview: Innoviva Specialty Therapeutics, Inc. , a subsidiary of Innoviva, Inc. , is a biopharmaceutical company developing and delivering innovative therapies in critical care[...]

MEHR INFOS ZUM STELLENANGEBOT

[...] care and infectious disease. Our approved treatments are indicated to address high unmet medical needs for serious conditions, and our investigational therapies are in development for patients fighting drug-resistant pathogens. Innoviva currently has three marketed medicines-GIAPREZA (angiotensin II) for the treatment of refractory hypotension in adults with septic or other distributive shock, XERAVA (eravacycline) for the treatment of complicated intra-abdominal infections (cIAI) , [...]

Job am 15.03.2025 bei NewScientist Jobs gefunden Verve Therapeutics, Inc.

Head of Biostatistics

• Boston, Massachusetts, United States, Boston Führungs-/ Leitungspositionen The Company Verve is a clinical-stage genetic medicines company established with a mission to solve the global health epidemic of cardiovascular disease. Founded by world-leading[...]

MEHR INFOS ZUM STELLENANGEBOT

[...] medicines company established with a mission to solve the global health epidemic of cardiovascular disease. Founded by world-leading experts in cardiovascular medicine, human genetics and gene-editing, Verve is pioneering a new approach to the care of cardiovascular disease, potentially transforming treatment from chronic management to single-course gene editing medicines. The company s initial three programs-VERVE-101, VERVE-102, and VERVE-201-target genes that have [...] atherosclerotic cardiovascular disease (ASCVD) patients not at goal on oral therapy. VERVE-201 is designed to permanently turn off the ANGPTL3 gene in the liver and is initially being developed for homozygous familial hypercholesterolemia (HoFH) and ultimately to treat patients with refractory hypercholesterolemia. In 2024, Verve was named a Top Place to Work by The Boston Globe for the fourth consecutive year. [...]
Alle Head Stellenangebote anzeigen

Refractory Treatment Stellenangebote

9 Stellenangebote

Stellenangebote Refractory Treatment Jobs

Biologist as Quality Assurance Manager (m/f/d)

Computational Immunologist

Pharmacovigilance Scientist

Director, Clinical Compliance and Oversight

Director/ Senior Director, Biostatistics

Clinical Trial Manager, Clinical Operations

Postdoctoral Research Fellow, Arvinas--Global Medical Affairs

Director, Clinical Science

Head of Biostatistics

Wieviele offene Stellenangebote gibt es für Refractory Treatment Jobs?

Zu welcher Branche gehören Refractory Treatment Jobs?